Reports for ALLERGAN INC
Company Name
ALLERGAN INC
Totals |
||
Shortage reports |
75 |
|
| Actual shortage: | 2 (3%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (4%) | |
| Resolved: | 69 (92%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 5 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
9 (11%) |
|
Overdue reports |
1 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2019-10-24 | 2019-11-08 | 97094 |
| BLEPHAMIDE | 10% 0.2% | DROPS | Resolved | 2020-04-03 | 2020-04-07 | 110845 |
| BLEPHAMIDE S.O.P. | 0.2% 10% | OINTMENT | Resolved | 2018-02-19 | 2019-11-08 | 40190 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2018-02-19 | 2018-04-21 | 40184 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2018-02-19 | 2018-04-21 | 40187 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2019-03-03 | 2019-04-15 | 77338 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2019-03-03 | 2019-04-19 | 77342 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84750 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2018-12-05 | 2019-02-08 | 68675 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84758 |
| BYSTOLIC | 10.0MG | TABLET | Resolved | 2019-01-29 | 2019-02-22 | 73787 |
| BYSTOLIC | 10.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-06 | 84746 |
| BYSTOLIC | 20.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84755 |
| CONSTELLA | 145MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-11 | 84767 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2018-11-20 | 2019-01-09 | 67153 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2019-02-19 | 2019-02-27 | 76263 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-07 | 84770 |
| CONSTELLA | 72MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-07 | 84773 |
| FETZIMA | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-05-25 | 2019-06-07 | 84776 |
| FETZIMA | 80MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-05-25 | 2019-06-07 | 84779 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALOCRIL | 2% | LIQUID | Discontinued | 2018-11-28 | 2019-04-02 | 67803 |
| ASACOL | 400MG | TABLET (ENTERIC-COATED) | Discontinued | 2020-07-31 | 2020-07-31 | 121616 |
| BETAGAN 0.5% OPHTHALMIC SOL | 5MG | LIQUID | Discontinued | 2020-03-10 | 2020-03-10 | 108380 |
| BETAGAN OPH SOLN 0.25% | 0.25% | LIQUID | Discontinued | 2017-08-04 | 2017-08-04 | 18275 |
| BLEPHAMIDE S.O.P. | 0.2% 10% | OINTMENT | Discontinued | 2019-07-31 | 2019-07-31 | 90343 |